OmniAb (OABI) Enterprise Value (2021 - 2026)
OmniAb (OABI) posted quarterly Enterprise Value of -$49.1 million for Q1 2026, down 12.56% year-over-year from -$56.1 million in Q1 2025, and down 1.01% quarter-over-quarter from -$48.6 million in Q4 2025.
OmniAb (OABI) Enterprise Value (2021 - 2026) Analysis & Trends
OmniAb (OABI) has reported Enterprise Value for 6 consecutive years, with -$49.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 12.56% year-over-year to -$49.1 million; the TTM figure through Mar 2026 stood at -$49.1 million (down 12.56% YoY), while the FY2025 annual figure was -$48.6 million, up 18.26% from the prior year.
- Enterprise Value fell to -$49.1 million in Q1 2026 per OABI's latest filing, from -$48.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$19847.0 in Q3 2022 and bottomed at -$113.6 million in Q1 2023.
- Historically, Enterprise Value has averaged -$57.5 million across 5 years, with a median of -$59.4 million in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 94.52% — and 2023, when it tumbled 486764.51%.
- OmniAb's Enterprise Value stood at -$88.3 million in 2022, then rose by 1.45% to -$87.0 million in 2023, then surged by 31.67% to -$59.4 million in 2024, then increased by 18.26% to -$48.6 million in 2025, then slipped by 1.01% to -$49.1 million in 2026.
- Business Quant data shows OABI's Enterprise Value at -$49.1 million in Q1 2026, -$48.6 million in Q4 2025, and -$59.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn | -52.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -52.00 Mn |
| Mar 31, 2026 | -49.07 Mn |
| Dec 31, 2025 | -48.58 Mn |
| Sep 30, 2025 | -59.50 Mn |
| Jun 30, 2025 | -41.62 Mn |
| Mar 31, 2025 | -43.60 Mn |
| Dec 31, 2024 | -59.43 Mn |
| Sep 30, 2024 | -59.38 Mn |
| Jun 30, 2024 | -57.23 Mn |
| Mar 31, 2024 | -69.01 Mn |
| Dec 31, 2023 | -86.98 Mn |
| Sep 30, 2023 | -96.63 Mn |
| Jun 30, 2023 | -103.15 Mn |
| Mar 31, 2023 | -113.61 Mn |
| Dec 31, 2022 | -88.27 Mn |
| Sep 30, 2022 | -19,847.00 |
| Jun 30, 2022 | -159,194.00 |
| Mar 31, 2022 | -434,629.00 |
| Sep 30, 2021 | -362,203.00 |
| Jun 30, 2021 | -36,145.00 |